My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Agro Tech Foods spurts after strong Q3 outcome
Jan 19,2017

The result was announced after market hours yesterday, 18 January 2017.

Meanwhile, the BSE Sensex was up 17.74 points, or 0.07%, to 27,275.38.

On the BSE, so far 28,000 shares were traded in the counter, compared with average daily volumes of 1,302 shares in the past one quarter. The stock had hit a high of Rs 521.50 and a low of Rs 458 so far during the day.

The stock hit a 52-week high of Rs 560 on 30 August 2016. The stock hit a 52-week low of Rs 422.05 on 23 December 2016. The stock had underperformed the market over the past 30 days till 18 January 2017, rising 2.87% compared with the 3.61% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 10.29% as against Sensexs 3.10% decline.

The small-cap company has equity capital of Rs 24.37 crore. Face value per share is Rs 10.

Agro Tech Foods is engaged in the business of marketing food and food ingredients to consumers. It is affiliated to ConAgra Foods, Inc. of USA, which is one the worlds largest food companies.

Powered by Capital Market - Live News

Cipla gains as arm to sell stake in Four M Propack to Shriji Polymers
Jan 19,2017

The announcement was made after market hours yesterday, 18 January 2017.

Meanwhile, the BSE Sensex was up 7.26 points, or 0.03%, to 27,264.90.

On the BSE, so far 3,742 shares were traded in the counter, compared with average daily volumes of 1.03 lakh shares in the past one quarter. The stock had hit a high of Rs 585 and a low of Rs 581.15 so far during the day.

The stock hit a 52-week high of Rs 617.70 on 23 September 2016. The stock hit a 52-week low of Rs 458.25 on 25 May 2016. The stock had underperformed the market over the past 30 days till 18 January 2017, rising 3.49% compared with the 3.61% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, falling 2.26% as against Sensexs 3.10% decline.

The large-cap company has equity capital of Rs 160.88 crore. Face value per share is Rs 2.

Cipla announced that its wholly-owned subsidiary Goldencross Pharma has entered in to a definitive agreement to sell its 100% equity stake in Four M Propack, India (Four M Propack) to Shriji Polymers (India) (Shriji Polymers) for a consideration of Rs 13.50 crore and an additional sum derived on the basis of the value of mutual funds, cash and bank balance, tax refunds, etc. at the time of closing estimated at around Rs 5.70 crore.

Shriji Polymers is engaged in the business of manufacturing of HDPE bottles and PP caps for the pharmaceutical industry. The turnover of Four M Propack for the financial year ended 31 March 2016 was Rs 9.77 crore which is entirely on account of sales to the company. The net worth of Four M Propack as on 31 March 2016 was Rs 15.82 crore constituting 0.001% of the consolidated net worth of the company. The transaction is expected to be completed within 45 days from date of signing of the definitive agreement, subject to completion of certain condition precedent and receipt of applicable approvals.

Cipla said that none of the persons belonging to promoter/promoter Group(s) of the company has any interest in the transaction and it is not a related party transaction for the company.

On a consolidated basis, Ciplas net profit dropped 34.75% to Rs 354.34 crore on 8.66% rise in net sales to Rs 3671.88 crore in Q2 September 2016 over Q2 September 2015.

Cipla is a global pharmaceutical company. Its portfolio includes over 1,000 products across wide range of therapeutic categories with one quality standard globally.

Powered by Capital Market - Live News

Cadila Healthcare gains after receiving final approval for Methotrexate tablets
Jan 18,2017

The announcement was made during market hours today, 18 January 2017.

Meanwhile, the BSE Sensex was up 21.98 points, or 0.08%, to 27,257.64

On the BSE, 93,000 shares were traded in the counter, compared with average daily volumes of 64,465 shares in the past one quarter. The stock had hit a high of Rs 359.30 and a low of Rs 351.30.

The stock hit a 52-week high of Rs 429.45 on 1 November 2016. The stock hit a 52-week low of Rs 295.50 on 18 January 2016. The stock had underperformed the market over the past 30 days till 17 January 2017, sliding 6.04% compared with the 3.26% rise in the Sensex. The scrip also underperformed the market in past one quarter, sliding 10.42% as against Sensexs 2.68% decline.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1

Cadila Healthcare said that the company has received final approval from the US Food and Drug Administration (USFDA) for Methotrexate tablets USP. 2.5 mg, a chemotherapy drug used for leukemias, lymphnomas, breast cancer, lung cancer, head and neck cancers and other cancers. The drug will be produced at groups formulations manufacturing facility at the pharma special economic zone in Ahmedabad. The group now has more than 105 approvals and has so far filed nearly 275 Abbreviated New Drug Applications (ANDAs) since the commencement of the filing process in the financial year ended 31 March 2004.

Cadila Healthcare during trading hours yesterday, 17 January 2017 announced settlement with Kowa Company, Kowa Pharmaceuticals America and Nissan Chemical Industries on Livalo tablets. The stock had gained 0.19% to settle at Rs 349.80 yesterday, 17 January 2017.

On a consolidated basis, net profit of Cadila Healthcare declined 28.97% to Rs 337.60 crore on 3.08% rise in net sales to Rs 2336.30 crore in Q2 September 2016 over Q2 September 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Indiabulls Housing Finance drops on profit booking
Jan 18,2017

Meanwhile, the S&P BSE Sensex was up 27.97 points or 0.1% at 27,263.63

On the BSE, 3.64 lakh shares were traded in the counter so far as against average daily volume of 1.40 lakh shares in the past one quarter. The stock had hit a high of Rs 777.50 and a low of Rs 753.45 so far during the day.

The stock had hit a record high of Rs 895 on 20 October 2016. The stock had hit a 52-week low of Rs 551 on 24 February 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 19.54% compared with the 3.26% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, sliding 11.89% as against Sensexs 2.68% decline.

The large-cap company has equity capital of Rs 84.75 crore. Face value per share is Rs 2.

Indiabulls Housing Finance had earlier this month announced that it has reduced its home loan rate by 45 basis points to 8.65% for its customers with effect from 3 January 2017.

Indiabulls Housing Finances consolidated net profit rose 23.2% to Rs 684.31 crore on 28.02% growth in total income to Rs 2874.95 crore in Q2 September 2016 over Q2 September 2015.

Indiabulls Housing Finance is a housing finance company. The company also provides other loans, such as loan against residential properties for home improvement and to small businesses, commercial vehicle loans, and corporate loans for housing projects.

Powered by Capital Market - Live News

Siemens gains after launching energy efficient motors in India
Jan 18,2017

The announcement was made during trading hours today, 18 January 2017.

Meanwhile, the BSE Sensex was up 21.63 points, or 0.08%, to 27,257.29.

On the BSE, so far 16,000 shares were traded in the counter, compared with average daily volumes of 18,409 shares in the past one quarter. The stock had hit a high of Rs 1,199.55 and a low of Rs 1,173 so far during the day.

The stock hit a 52-week high of Rs 1,355.40 on 25 July 2016. The stock hit a 52-week low of Rs 969 on 29 January 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 5.72% compared with the 3.26% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 4.70% as against Sensexs 2.68% decline.

The large-cap company has equity capital of Rs 71.22 crore. Face value per share is Rs 2.

Siemens announced the launch of its new range of energy efficient motor SIMOTICS 1LE7. The new SIMOTICS 1LE7 range of motors is the newest entrant in the existing range of motors offered by Siemens in India. These motors offer efficiency values higher than the IE3 standards - which is currently the highest efficiency class as recognized by Indian Standards. Siemens SIMOTICS 1LE7 motors are capable of offering an average monetary savings of up to 8-20% depending on the frame size. Apart from generating savings, the SIMOTICS 1LE7 range of motors will assist customers to reduce lifecycle costs, and meet environmental regulations.

Bhaskar Mandal, executive vice president and country division lead, process industries & drives division, Siemens India, said SIMOTICS 1LE7 will prove to be a reliable and efficient innovation which will boost the performance of energy intensive industries like cement, metals, mining, power, textiles, pulp and paper to achieve significant reduction in energy consumption and thus reduce costs of operation and their carbon footprint.

Net profit of Siemens rose 1025.8% to Rs 2466.95 crore on 7.5% decline in net sales to Rs 2990.30 crore in Q4 September 2016 over Q4 September 2015.

Siemens focuses on the areas of electrification, automation and digitalization.

Powered by Capital Market - Live News

Volumes jump at IST counter
Jan 18,2017

IST clocked volume of 2.80 lakh shares by 13:19 IST on BSE, a 2718.93-times surge over two-week average daily volume of 103 shares. The stock rose 1.45% to Rs 770.

Transformers and Rectifiers (India) notched up volume of 2.12 lakh shares, a 72.37-fold surge over two-week average daily volume of 2,932 shares. The stock jumped 18.9% to Rs 447.

Faze Three saw volume of 12.54 lakh shares, a 29.91-fold surge over two-week average daily volume of 42,000 shares. The stock surged 10.38% to Rs 79.75.

Bharat Bijlee clocked volume of 66,000 shares, a 21.53-fold surge over two-week average daily volume of 3,000 shares. The stock gained 9.72% to Rs 916.95.

United Spirits saw volume of 1.95 lakh shares, a 6.93-fold rise over two-week average daily volume of 28,000 shares. The stock rose 5.51% to Rs 2,194.35.

Powered by Capital Market - Live News

Reliance Defence gains after delivering bulk carrier to international client
Jan 18,2017

The announcement was made during trading hours today, 18 January 2017.

Meanwhile, the BSE Sensex was up 53.99 points, or 0.20%, to 27,289.65.

On the BSE, so far 2.28 lakh shares were traded in the counter, compared with average daily volumes of 6.34 lakh shares in the past one quarter. The stock had hit a high of Rs 58.20 and a low of Rs 56.65 so far during the day.

The stock hit a 52-week high of Rs 81.15 on 21 January 2016. The stock hit a 52-week low of Rs 48.40 on 22 November 2016. The stock had underperformed the market over the past 30 days till 17 January 2017, rising 2.99% compared with the 3.26% rise in the Sensex. The scrip had also underperformed the market in past one quarter, falling 6.34% as against Sensexs 2.68% decline.

The mid-cap company has equity capital of Rs 736.21 crore. Face value per share is Rs 10.

Reliance Defence and Engineering (RDEL) said it delivered yet another 74,500 deadweight tonage (DWT) new-built ice-class Panamax bulk carrier, Sea Amber, on 17 January 2017 to an international customer.

Reliance Shipyard has delivered till date seven similar size, ice-class Panamax vessels to its international customers. The ship has been built as per one of the best-in-class international standards meeting the toughest environmental emission norms as well as fuel economy (EEDI standard). These are the largest dry bulk carriers of its class ever built in India. RDEL is the only Indian shipyard to achieve this landmark, the company said.

Reliance Defence & Engineering reported net loss of Rs 116.29 crore in Q2 September 2016 as against net loss of Rs 170.49 crore in Q2 September 2015. Net sales rose 86.3% to Rs 96.85 crore in Q2 September 2016 over Q2 September 2015.

Reliance Defence and Engineering (RDEL) has the largest engineering infrastructure in India and is one of the largest in the world. The company is the first private sector company in India to obtain the licence and contract to build warships.

Powered by Capital Market - Live News

Swan Energy gains after receiving EOI for subsidiarys stake
Jan 18,2017

The announcement was made during market hours today, 18 January 2017.

Meanwhile, the S&P BSE Sensex was up 46.18 points, or %, to 27,281.84

On the BSE, so far 4.53 lakh shares were traded in the counter, compared with average daily volumes of 5.55 lakh shares in the past one quarter. The stock had hit a high of Rs 182.80 and a low of Rs 176.25 so far during the day.

The stock hit a record high of Rs 213.40 on 14 December 2016. The stock hit a 52-week low of Rs 57.50 on 16 May 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 7.24% compared with the 3.26% rise in the Sensex. The scrip had also outperformed the market in past one quarter, surging 69.58% as against Sensexs 2.68% decline.

The mid-cap company has equity capital of Rs 22.12 crore. Face value per share is Re 1.

Swan Energys net profit jumped 1170.6% to Rs 2.16 crore on 1.6% growth in net sales to Rs 96.09 crore in Q2 September 2016 over Q2 September 2015.

Swan Energy is engaged in the manufacturing of textile products. The company is also engaged in the real estate development and energy businesses.

Powered by Capital Market - Live News

Tata Elxsi jumps on buzz of testing driverless car
Jan 18,2017

Meanwhile, the BSE Sensex was up 80.86 points, or 0.30%, to 27,316.52.

On the BSE, so far 3.23 lakh shares were traded in the counter, compared with average daily volumes of 83,294 shares in the past one quarter. The stock had hit a high of Rs 1,521.35 and a low of Rs 1,443.10 so far during the day.

The stock hit a record high of Rs 2,396 on 2 February 2016. The stock hit a 52-week low of Rs 1,021.65 on 21 November 2016. The stock had underperformed the market over the past 30 days till 17 January 2017, rising 0.64% compared with the 3.26% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 5.15% as against Sensexs 2.68% decline.

The mid-cap company has equity capital of Rs 31.14 crore. Face value per share is Rs 10.

According to a media report, Tata Elxsi is looking to test an autonomous, or driverless, car out on the roads of Bengaluru. This would be a first in the country. Currently, all major automobile manufacturers as well as technology firms of the Silicon Valley, such as Google, Apple, Uber and Tesla, are building and testing autonomous vehicles. Cars that will drive themselves could be common on the streets by 2025, the report said.

Tata Elxsi works with carmakers and their specialised component suppliers. It is leveraging its knowledge in computer science and artificial Intelligence to grab a share of the soon to be multi-billion dollar global industry. It has already begun simulating and testing autonomous cars at a facility on the outskirts of Bengaluru, the report added.

Net profit of Tata Elxsi rose 13.1% to Rs 43.08 crore on 15% rise in net sales to Rs 303.29 crore in Q2 September 2016 over Q2 September 2015.

Tata Elxsi is amongst the worlds leading providers of design and technology services for product engineering and solutions across industries including broadcast, communications and automotive.

Powered by Capital Market - Live News

Panacea Biotec jumps on report USFDA approves migraine drug
Jan 18,2017

Meanwhile, the BSE Sensex was up 136.42 points, or 0.50%, to 27,372.08.

On the BSE, so far 1.09 lakh shares were traded in the counter, compared with average daily volumes of 15,624 shares in the past one quarter. The stock had hit a high of Rs 143.60 and a low of Rs 134.20 so far during the day.

The stock hit a 52-week high of Rs 155 on 25 July 2016. The stock hit a 52-week low of Rs 83.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 4.17% compared with the 3.26% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 15.93% as against Sensexs 2.68% decline.

The small-cap company has equity capital of Rs 6.13 crore. Face value per share is Re 1.

According to reports, Panacea Biotec received the US Food and Drug Administrations (USFDA) approval for Rizatripan Bonzoate tablet, which is used in treating symptoms due to migraine.

Panacea Biotec reported net loss of Rs 11.84 crore in Q2 September 2016, lower than net loss of Rs 17 crore in Q2 September 2015. Net sales declined 18.3% to Rs 131.56 crore in Q2 September 2016 over Q2 September 2015.

Panacea Biotec is one of Indias leading research based biotechnology companies with established research, manufacturing and marketing capabilities.

Powered by Capital Market - Live News

Rama Steel Tubes gains as board to consider raising funds
Jan 18,2017

The announcement was made after market hours yesterday, 17 January 2017.

Meanwhile, the S&P BSE Sensex was up 136.05 points or 0.5% at 27,371.71.

On the BSE, 5,784 shares were traded on the counter so far as against the average daily volumes of 11,208 shares in the past one quarter. The stock had hit a high of Rs 113.75 and a low of Rs 111.95 so far during the day.

The stock had hit a record high of Rs 148 on 26 October 2016 and a 52-week low of Rs 82.23 on 8 March 2016. The stock had underperformed the market over the past one month till 17 January 2017, declining 3.78% compared with the Sensexs 2.82% rise. The scrip had also underperformed the market over the past one quarter declining 16.82% as against the Sensexs 1.07% fall.

The small-cap company has equity capital of Rs 7.47 crore. Face value per share is Rs 5.

Rama Steel Tubes fund raising proposal is subject to its shareholders approval.

Rama Steel Tubes consolidated net profit rose 62.7% to Rs 2.62 crore on 4.5% fall in net sales to Rs 58.82 crore in Q2 September 2016 over Q2 September 2015.

Rama Steel Tubes deals in manufacturing, supplying and exporting of steel pipes, steel tubes and fittings.

Powered by Capital Market - Live News

PVR scales record high after large bulk deal
Jan 18,2017

Meanwhile, the S&P BSE Sensex was up 142.74 points, or 0.52%, to 27,378.40

On BSE, so far 34,000 shares were traded in the counter, compared with average daily volume of 7,612 shares in the past one quarter. The stock hit a high of Rs 1,489.50 in intraday trade so far, which is record high for the counter. The stock hit a low of Rs 1,241.65 so far during the day. The stock hit a 52-week low of Rs 646 on 25 February 2016.

The stock had outperformed the market over the past 30 days till 17 January 2017, rising 14.74% compared with the 3.26% rise in the Sensex. The scrip had also outperformed the market in past one quarter, rising 3.3% as against Sensexs 2.68% decline.

The mid-cap company has equity capital of Rs 46.74 crore. Face value per share is Rs 10.

On a consolidated basis, net profit of PVR declined 4.93% to Rs 29.13 crore on 16.26% rise in net sales to Rs 541.01 crore in Q2 September 2016 over Q2 September 2015.

PVR is the largest and the most premium film and retail entertainment company in India.

Powered by Capital Market - Live News

Mercator drops after announcing pricing of QIP issue
Jan 18,2017

The announcement was made after market hours yesterday, 17 January 2017.

Meanwhile, the S&P BSE Sensex was up 137.81 points or 0.51% at 27,373.47

On the BSE, 1.96 lakh shares were traded on the counter so far as against average daily volumes of 2.90 lakh shares in the past one quarter. The stock hit a high of Rs 44.60 and a low of Rs 42.60 so far during the day.

The stock had hit a 52-week high of Rs 54.55 on 6 September 2016. The stock had hit a 52-week low of Rs 15.90 on 12 February 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 16.43% compared with the 3.26% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, sliding 10.95% as against Sensexs 2.68% decline.

The small-cap company has equity capital of Rs 24.49 crore. Face value per share is Re 1.

Mercator said that the qualified institutional placement (QIP) committee of the company has approved the issue price of Rs 40.75, after giving discount of 4.79% i.e. Rs 2.05 per share, on the floor price of Rs 42.80 per share for the shares to be issued and allotted to eligible qualified institutional buyers. The QIP committee also approved issue of confirmation allocation note for the allocation of 2.50 crore shares to the qualified institutional buyers.

Mercator reported net loss of Rs 27.05 crore in Q2 September 2016 compared with net profit of Rs 14.59 crore in Q2 September 2015. Net sales declined 19.58% to Rs 133.28 crore in Q2 September 2016 over Q2 September 2015.

Mercator group has business interests in coal, oil & gas, shipping and dredging.

Powered by Capital Market - Live News

United Spirits spurts on report Diageo Plc plans to hike stake
Jan 18,2017

Meanwhile, the BSE Sensex was up 137.18 points, or 0.50%, to 27,372.84.

On the BSE, so far 1.38 lakh shares were traded in the counter, compared with average daily volumes of 26,445 shares in the past one quarter. The stock had hit a high of Rs 2,232 and a low of Rs 2,100 so far during the day.

The stock hit a 52-week high of Rs 2,864.75 on 25 January 2016. The stock hit a 52-week low of Rs 1,775.05 on 22 November 2016. The stock had outperformed the market over the past 30 days till 17 January 2017, rising 7.77% compared with the 3.26% rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 14.21% as against Sensexs 2.68% decline.

The large-cap company has equity capital of Rs 145.33 crore. Face value per share is Rs 10.

According to reports, Diageo Plc is considering increasing its majority stake in Indian whiskey producer United Spirits. Diageo is reportedly planning an open offer to the other shareholders in United Spirits.

Relay B.V., an indirect wholly-owned subsidiary of Diageo Plc, holds 54.78% stake in United Spirits (as per the shareholding pattern as on 31 December 2016). Under Indian stock market regulations, Diageo could raise its stake to just under 75% without triggering a delisting offer.

Diageo gained complete control of the board of United Spirits post the exit of Dr Vijay Mallya from his position as chairman and non-executive director of United Spirits in February 2016.

Meanwhile, United Spirits announced after market hours yesterday, 17 January 2017, that ICRA has revised the long-term rating outstanding on the Rs 2900 crore term loan facilities (revised from Rs 3000 crore) of United Spirits to [ICRA]AA (pronounced as ICRA double A)2 from [ICRA]A+ (pronounced as ICRA A plus). The outlook on the long term rating is Positive.

ICRA has also reaffirmed the short-term rating outstanding on the Rs 2400 crore fund based facilities and the Rs 400 crore non-fund based facilities of USL at [ICRA]A1 + (pronounced as ICRA A one plus).

ICRA also has reaffirmed the rating outstanding of [ICRA]A1+ (pronounced ICRA A one plus) on the Rs 1000 crore commercial paper programme of the company.

Net profit of United Spirits rose 15.9% to Rs 82.54 crore on 7.7% rise in net sales to Rs 2037.70 crore in Q2 September 2016 over Q2 September 2015.

United Spirits makes alcoholic beverages. It is a subsidiary of British multinational Diageo plc.

Powered by Capital Market - Live News

New orders boost Bharat Wire Ropes
Jan 18,2017

The announcement was made after market hours yesterday, 17 January 2017.

Meanwhile, the S&P BSE Sensex was up 157.57 points or 0.58% at 27,393.23.

On the BSE, 80,000 shares were traded on the counter so far as against the average daily volumes of 1.78 lakh shares in the past one quarter. The stock had hit a high of Rs 86.20 so far during the day, which is also its record high. The stock had hit a low of Rs 83.35 so far during the day.

The stock had hit a record low of Rs 38 on 31 May 2016. The stock had outperformed the market over the past one month till 17 January 2017, advancing 60.98% compared with the Sensexs 2.82% rise. The scrip had also outperformed the market over the past one quarter advancing 90.27% as against the Sensexs 1.07% fall.

The small-cap company has equity capital of Rs 44.95 crore. Face value per share is Rs 10.

Bharat Wire Ropes said that it has booked orders of about Rs 8 crore which also constitutes a defense order of about Rs 6.5 crore. The company has bid for various projects and the outstanding bids/offers are for about Rs 60 crore, which are at various stages of evaluation.

Bharat Wire Ropes net profit rose 17.1% to Rs 0.41 crore on 42.6% rise in net sales to Rs 16.69 crore in Q2 September 2016 over Q2 September 2015.

Bharat Wire Ropes is engaged in manufacturing of wire ropes and slings for use in a varied list of application/industries such as general engineering, fishing, elevators, cranes, material handling, onshore/offshore oil exploration, ports and shipping and mining.

Powered by Capital Market - Live News